Pharmaceuticals news FT.com

Pfizer to halt development of closely watched weight-loss drug

US pharmaceutical group says patient in study experienced ‘potential drug-induced liver injury’

May 12, 2025 - 10:14
 0
Pfizer to halt development of closely watched weight-loss drug
US pharmaceutical group says patient in study experienced ‘potential drug-induced liver injury’
Read More

Tags:

Previous Article

J&J warns pharma tariffs could cause drug shortages

Next Article

NHS signs deal with Scancell in ambitious skin cancer trial

Related Posts

Novo Nordisk joins finance’s great one-hit wonders

Novo Nordisk joins finance’s great one-hit wonders

May 21, 2025  0

Biotech billionaire Christian Angermayer: ‘Psychedelics can take away the fear’

Biotech billionaire Christian Angermayer: ‘Psychedelics...

May 18, 2025  0

Novo Nordisk partners with US biotech to boost pipeline of new obesity drugs

Novo Nordisk partners with US biotech to boost pipeline...

May 14, 2025  0